Promising Alzheimer's drug approved for late-stage trials - USA Today
![]() eFluxMedia |
Promising Alzheimer's drug approved for late-stage trials
USA Today - By Mary Brophy Marcus, USA TODAY An experimental drug for Alzheimer's disease patients showed promise in Phase II clinical trials and is moving into final-stage trials, Wyeth and Elan, the makers of bapineuzumab, announced Tuesday. Wyeth, Elan Rise After Alzheimer's Drug Improves With Gene Test Elan climbs to 6-year high on study results |































